Article Details

Cassava closes the door on controversy, for now - Pharmaceutical Technology

Retrieved on: 2022-02-21 17:06:25

Tags for this article:

Click the tags to see associated articles and topics

Cassava closes the door on controversy, for now - Pharmaceutical Technology. View article details on hiswai:

Excerpt

... and Eisai's anti-amyloid monoclonal antibody Aduhelm (aducanumab), ... including anti-amyloid beta monoclonal antibodies such as Roche's ...

Article found on: www.pharmaceutical-technology.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up